Dawson L, Alshawabkeh M, Schroer K, Arakrak F, Ehrhardt A, Zhang W
Eng Microbiol. 2024; 4(1):100140.
PMID: 39628785
PMC: 11611009.
DOI: 10.1016/j.engmic.2024.100140.
Riedl A, Fischer J, Burgert H, Ruzsics Z
Front Microbiol. 2022; 13:854690.
PMID: 35369433
PMC: 8975557.
DOI: 10.3389/fmicb.2022.854690.
Vujadinovic M, Wunderlich K, Callendret B, Koning M, Vermeulen M, Sanders B
Hum Gene Ther. 2017; 29(3):337-351.
PMID: 28816084
PMC: 5865256.
DOI: 10.1089/hum.2017.023.
Draper S, Heeney J
Nat Rev Microbiol. 2009; 8(1):62-73.
PMID: 19966816
DOI: 10.1038/nrmicro2240.
Ugai H, Borovjagin A, Le L, Wang M, Curiel D
J Mol Biol. 2007; 366(4):1142-60.
PMID: 17208253
PMC: 2203208.
DOI: 10.1016/j.jmb.2006.11.090.
Adenoviruses as vaccine vectors.
Tatsis N, Ertl H
Mol Ther. 2004; 10(4):616-29.
PMID: 15451446
PMC: 7106330.
DOI: 10.1016/j.ymthe.2004.07.013.
Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice.
Gyorffy S, Palmer K, Gauldie J
Am J Pathol. 2001; 159(3):1137-47.
PMID: 11549607
PMC: 1850460.
DOI: 10.1016/S0002-9440(10)61790-7.
Recombinational construction in Escherichia coli of infectious adenoviral genomes.
Crouzet J, Naudin L, Orsini C, Vigne E, Ferrero L, Le Roux A
Proc Natl Acad Sci U S A. 1997; 94(4):1414-9.
PMID: 9037067
PMC: 19805.
DOI: 10.1073/pnas.94.4.1414.
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli.
Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, Mehtali M
J Virol. 1996; 70(7):4805-10.
PMID: 8676512
PMC: 190422.
DOI: 10.1128/JVI.70.7.4805-4810.1996.
Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors.
Amalfitano A, Begy C, Chamberlain J
Proc Natl Acad Sci U S A. 1996; 93(8):3352-6.
PMID: 8622940
PMC: 39611.
DOI: 10.1073/pnas.93.8.3352.
Packaging capacity and stability of human adenovirus type 5 vectors.
Bett A, Prevec L, Graham F
J Virol. 1993; 67(10):5911-21.
PMID: 8371349
PMC: 238011.
DOI: 10.1128/JVI.67.10.5911-5921.1993.
An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.
Bett A, Haddara W, Prevec L, Graham F
Proc Natl Acad Sci U S A. 1994; 91(19):8802-6.
PMID: 8090727
PMC: 44694.
DOI: 10.1073/pnas.91.19.8802.
Adenovirus-mediated gene transfer into striated muscles.
Acsadi G, Massie B, Jani A
J Mol Med (Berl). 1995; 73(4):165-80.
PMID: 7627637
DOI: 10.1007/BF00188137.
Methods for construction of adenovirus vectors.
Graham F, Prevec L
Mol Biotechnol. 1995; 3(3):207-20.
PMID: 7552690
DOI: 10.1007/BF02789331.
A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells.
Clarke M, Apel I, Benedict M, Eipers P, Sumantran V, Gonzalez-Garcia M
Proc Natl Acad Sci U S A. 1995; 92(24):11024-8.
PMID: 7479929
PMC: 40563.
DOI: 10.1073/pnas.92.24.11024.
Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes.
Haj-Ahmad Y, Graham F
EMBO J. 1987; 6(6):1733-9.
PMID: 3038533
PMC: 553549.
DOI: 10.1002/j.1460-2075.1987.tb02425.x.
Infectious circular DNA of human adenovirus type 5: regeneration of viral DNA termini from molecules lacking terminal sequences.
Graham F, Rudy J, Brinkley P
EMBO J. 1989; 8(7):2077-85.
PMID: 2792081
PMC: 401095.
DOI: 10.1002/j.1460-2075.1989.tb03616.x.
Adenoviruses with nonidentical terminal sequences are viable.
Lippe R, Graham F
J Virol. 1989; 63(12):5133-41.
PMID: 2585600
PMC: 251176.
DOI: 10.1128/JVI.63.12.5133-5141.1989.